Respiratory Disease

Urine Test Could Help Assess Aspects of Cystic Fibrosis

New research provides insights on the effects of cystic fibrosis in the kidneys, pointing to the potential for a urine test related to the disease.

Respiratory Disease

Cost-Effective Tests for Lyme Disease and TBRF

IGeneX’s new BCA assays are simple and cost-effective tests that give either a positive or negative result for exposure to Borrelia spp.

Respiratory Disease

Reimbursement for Molecular Respiratory Pathogen Testing

Over time, the American Medical Association has established specific current procedural terminology codes to be used in reporting the results of testing by means of such multiplex molecular pathology panels.

FDA Clears Respiratory Panel That Can Detect More Than 20 Pathogens

Jul 9, 2019 | Gastrointestinal Infections, Respiratory Disease, Swabs

The panel is the first offering in a deep and broad pipeline of assays planned for QIAstat-Dx in the United States.

University of Manchester and Owlstone Medical Awarded £250,000 to Advance Asthma Diagnostics

Mar 25, 2019 | Cardiovascular, Research, Respiratory Disease

The study will collect breath samples from asthmatic patients and healthy controls to analyze breath-based biomarkers.

BD Launches Molecular Test for Tuberculosis

Nov 20, 2018 | Molecular Diagnostics, Respiratory Disease, Tuberculosis, Womens Health

The BD Max MDR-TB panel has obtained the CE mark, supporting market launch in Europe.

SenzaGen Launches First In Vitro Airway Allergy Test

Oct 28, 2018 | Allergy & Autoimmune, Culture Media, Respiratory Disease

The test uses genetic biomarkers to determine with high accuracy whether inhaled substances and chemicals that come into contact with the lungs are allergenic or not.

Hologic Panther Fusion System and Respiratory Assays Approved by Health Canada

Jul 28, 2018 | Culture Media, Respiratory Disease

New module expands molecular testing capabilities, increases productivity and flexibility for the laboratory.

EliTechGroup Molecular Diagnostics Receives CE Mark for Respiratory Panel

Mar 28, 2018 | Flu & Respiratory Infections, Immunoassay, Immunoassay Reagents & test Kits, Infectious Diseases, Molecular Diagnostics, Respiratory Disease

liTechGroup Molecular Diagnostics has launched a multiplex assay, the respiratory bacterial Elite MGB panel, for the diagnosis of bacterial respiratory infections.

Third Hologic Respiratory Assay Obtains FDA Clearance

Jan 3, 2018 | Culture Media, Respiratory Disease

Running on the company’s Panther Fusion system, the new assay detects adenovirus, human metapneumovirus, and rhinovirus.

Respiratory Assay Cleared for Use on Panther Fusion System

Nov 14, 2017 | Flu & Respiratory Infections, Infectious Diseases, Molecular Diagnostics, Respiratory Disease

Hologic has received premarket notification (510(k)) clearance from FDA for its Panther Fusion Flu A/B/RSV assay running on the company’s new Panther Fusion system.

IDbyDNA, ARUP Laboratories Introduce Technology to Diagnose Respiratory Infections

Oct 30, 2017 | Flu & Respiratory Infections, Infectious Diseases, Molecular Diagnostics, Respiratory Disease

ARUP Laboratories and IDbyDNA have announced the launch of Explify Respiratory, a next-generation sequencing test for respiratory infections.

FDA Clears GenMark Instrument, Respiratory Pathogen Panel

Aug 7, 2017 | Flu & Respiratory Infections, Infectious Diseases, Molecular Diagnostics, Respiratory Disease

The ePlex diagnostic platform integrates nucleic acid extraction, amplification, and detection into a fully automated, sample-to-answer system.

Advancing Tuberculosis Testing

May 5, 2017 | Disease States, Flu & Respiratory Infections, Molecular Diagnostics, Respiratory Disease, Tuberculosis

Protecting sample stability ensures the utility of the latest generation of TB tests.

Professional Societies Issue Guidance on Molecular Diagnostics System for Respiratory Isolation Decisions

Jun 28, 2016 | Molecular Diagnostics, Respiratory Disease

The US National Tuberculosis Controllers Association and the Association of Public Health Laboratories have recommended the use of the Xpert MTB/RIF test to support decisionmaking on using airborne infection isolation in healthcare settings.